If evidence based risk is identified through research then the product CorMatrix should be identified as high risk for failure to surgeons. And an alternative be suggested to search for that is approved by this authority, for example CardioCel.
Happy to help. now off for a drive.
MB
- Forums
- ASX - By Stock
- AVR
- More on cormatrix
AVR
anteris technologies global corp.
Add to My Watchlist
5.16%
!
$5.91

More on cormatrix, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.91 |
Change
0.290(5.16%) |
Mkt cap ! $91.59M |
Open | High | Low | Value | Volume |
$5.79 | $6.19 | $5.79 | $17.15K | 2.906K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38 | $5.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.10 | 170 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38 | 5.900 |
1 | 1000 | 5.850 |
1 | 104 | 5.800 |
2 | 3500 | 5.600 |
1 | 3045 | 5.510 |
Price($) | Vol. | No. |
---|---|---|
6.100 | 170 | 1 |
6.200 | 500 | 1 |
6.300 | 100 | 1 |
6.400 | 450 | 2 |
6.550 | 1092 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online